Revelation Biosciences Inc (REVB) — Strategic Asset Allocation Index
Revelation Biosciences Inc (REVB) has a Strategic Asset Allocation Index of 0.7% as of June 2023. Strategic assets (PP&E of $77.61K plus long-term investments of $-) total $77.61K, measured against net assets of $11.41 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Revelation Biosciences Inc (REVB) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Revelation Biosciences Inc Strategic Asset Allocation Index (2016–2018)
This chart shows how Revelation Biosciences Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2016 to 2018. As of June 2023, the index stands at 0.7%, representing strategic assets of $77.61K against net assets of $11.41 Million USD. For live market cap and overall valuation, see REVB market cap overview.
Annual Strategic Asset Allocation Index for Revelation Biosciences Inc (2016–2018)
The table below presents the year-by-year Strategic Asset Allocation Index for Revelation Biosciences Inc from 2016 to 2018, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See REVB net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2018 | 74.2% | $196.54 Million | $4.28 Million | $192.26 Million | $264.89 Million | ▼ -17.5 pp |
| 2017 | 91.7% | $172.60 Million | $4.23 Million | $168.38 Million | $188.28 Million | ▲ +5.8 pp |
| 2016 | 85.9% | $144.91 Million | $- | $144.91 Million | $168.76 Million | — |